Description
The abstract identifies AGEs as major crosslinkers causing neurofilament transformation to Lewy bodies but doesn’t explain the specific biochemical processes involved. Understanding these mechanisms is critical for developing targeted interventions to prevent Lewy body formation.
Gap type: unexplained_observation Source paper: Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress? (1998, Annals of neurology, PMID:9749578)
Resolution criteria
Resolved when AGE-driven conversion of soluble neurofilaments into insoluble Lewy-body-like aggregates is biochemically characterized. Required evidence: in vitro glycation/crosslinking time courses with mass spectrometry site mapping, aggregation kinetics, co-aggregation with alpha-synuclein or ubiquitin/p62 markers, neuronal oxidative-stress models, and inhibition by AGE blockers or crosslink breakers. Closure requires identifying specific AGE adducts/crosslinks that are necessary for insoluble aggregate formation.